Immunotherapy is an exciting new cancer treatment. Here you can learn about immune cell gene therapy: what it is, how it’s done, and when it’s used.

On February 13, Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative allogeneic chimeric antigen receptor (CAR) T-cell therapy ...

Colorectal cancer (CRC) is the second most common cause of death from cancer in the US and the most prevalent malignant tumor ...

Illustration of T lymphocyte white blood cells (blue) attacking a cancer cell (red). CAR-T therapy is a type of immunotherapy that genetically modifies a patient's own T cells to recognise and ...

CAR T-cell therapy is also presently used among patients with cancers that have returned after an initial successful treatment or which haven’t responded to previous combinations of chemotherapy ...

CAR-T therapy is an immunotherapy which involves reprogramming T cells to better attack tumors. In the illustration above, a T cell, in brown, can be seen attacking cancer cells, in purple.

CAR-T cell therapy has been the darling of the oncology world for more than a decade, where it’s had most success against blood cancers. That includes acute B cell lymphoblastic leukemia and B ...

A new study suggests a simple blood test -- administered before CAR-T cell treatment is initiated -- may identify which patients are predisposed to developing neurotoxic side effects in the days ...